News About: Pharm. Industry
Dispute over deposit designation system subsides
Discord over the deposit designation system, which has been promoted by the Korea Pharmaceutical Manufacturers Association to support scientific events has reportedly subsided as the Fair Trade Commission finally agre...
Kukje to launch Novasc generic
Kukje Pharm says it plans to market amlodipine 5 mg as Pfizer's Novasc generic drug from January 21, despite the current patent lawsuit over amlodipne between Pfizer Korea and Ahngook Pharm.
We decided to launch am...
Establishment of new GMP training center eyed
The government says the establishment of new GMP (good manufacturing practices) center is being promoted with an aim to nurture local GMP professionals, instead of utilizing the existing drug manufacturer's facility a...
Plavix patent war getting fiercer
A paten war, ignited by Korean pharmaceutical firms, is getting fiercer as Sanofi-Aventis Korea unveiled its plan to defend its original Plavix patent with all possible legal means on January 15.
Experts cite growi...
29 drug manufacturers keen on toll manufacturing
29 GMP-owned pharmaceutical firms are keenly interested in toll manufacturing of pharmaceuticals, according to a local survey.
The Korea Pharmaceutical Manufacturers Association says that its survey of 45 drug make...
14 drug makers and 8 wholesalers to face probe
The government is considering a fresh investigation into 14 domestic medium-sized pharmaceutical firms and eight wholesalers (annual sales: 60 to 70 billion won) in relation to undue business practice.
To that end,...
Janssen Korea seeks to strengthen presence in Asian market
Janssen Korea says it will focus on expanding its presence in the Asian and Pacific region this year, as a production base for exporting Ultracet (acetaminophen+tramadol) and Nizoral (ketoconazole) after remodeling it...
More focus on new drug projects, experts say
Korea should seek to expand its spending in research and development (R&D) as part of efforts to cope with in the era of free trade agreements (FTAs), experts point out.
They emphasize that the government should st...
Pfizer Korea wins 'Drug Safety Monitoring Award'
Pfizer Korea won the annual Drug Safety Monitoring Award for consecutive three years from the Korea Food and Drug Administration.
The award is given a company or medical institution that made voluntary reports on s...
VGX International to initiate Phase I clinical studies of VGX-1027
VGX International is planning to conduct its Phase I clinical studies of VGX-1027, a novel small molecule compound with potent anti-inflammatory activity, in healthy volunteers jointly with its affiliate, VGX Pharmace...
